MENU
+Compare
CLPBY
Stock ticker: OTC
AS OF
Dec 2 closing price
Price
$8.88
Change
-$0.20 (-2.20%)
Capitalization
20.33B

CLPBY Coloplast AS Forecast, Technical & Fundamental Analysis

Coloplast is a leading global competitor in ostomy management and continence care... Show more

CLPBY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CLPBY with price predictions
Nov 28, 2025

CLPBY in upward trend: price rose above 50-day moving average on November 25, 2025

CLPBY moved above its 50-day moving average on November 25, 2025 date and that indicates a change from a downward trend to an upward trend. In of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where CLPBY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CLPBY advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 206 cases where CLPBY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CLPBY as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CLPBY turned negative on November 14, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for CLPBY crossed bearishly below the 50-day moving average on November 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLPBY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.170) is normal, around the industry mean (9.233). P/E Ratio (36.243) is within average values for comparable stocks, (163.343). Projected Growth (PEG Ratio) (2.327) is also within normal values, averaging (2.548). CLPBY has a moderately high Dividend Yield (0.035) as compared to the industry average of (0.016). P/S Ratio (4.728) is also within normal values, averaging (110.831).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CLPBY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLPBY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
CLPBY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CLPBY is expected to report earnings to rise 33.24% to 9 cents per share on February 06

Coloplast AS CLPBY Stock Earnings Reports
Q4'25
Est.
$0.10
Q3'25
Missed
by $0.03
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.02
The last earnings report on November 04 showed earnings per share of 7 cents, missing the estimate of 10 cents. With 601.58K shares outstanding, the current market capitalization sits at 20.33B.
A.I.Advisor
published Dividends

CLPBY paid dividends on May 22, 2025

Coloplast AS CLPBY Stock Dividends
А dividend of $0.08 per share was paid with a record date of May 22, 2025, and an ex-dividend date of May 16, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Holtedam 1-3
Phone
+45 49111111
Employees
15913
Web
https://www.coloplast.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NSI33.240.28
+0.84%
National Security Emerging Mkts Idx ETF
KRMA44.160.24
+0.55%
Global X Conscious Companies ETF
DFIV48.390.18
+0.37%
Dimensional International Value ETF
QLC80.780.17
+0.21%
FlexShares US Quality Large Cap ETF
NCLO25.02-0.02
-0.10%
Nuveen AA-BBB CLO ETF

CLPBY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPBY has been loosely correlated with CLPBF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBY jumps, then CLPBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBY
1D Price
Change %
CLPBY100%
N/A
CLPBF - CLPBY
38%
Loosely correlated
N/A
SAUHY - CLPBY
34%
Loosely correlated
N/A
SMMNY - CLPBY
33%
Poorly correlated
N/A
SONVY - CLPBY
32%
Poorly correlated
N/A
ESLOY - CLPBY
32%
Poorly correlated
N/A
More

Groups containing CLPBY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBY
1D Price
Change %
CLPBY100%
N/A
Pharmaceuticals
category (377 stocks)
39%
Loosely correlated
+0.67%
Pharmaceuticals: Other
category (103 stocks)
34%
Loosely correlated
+0.77%